Carcinoid Heart Disease

Slide 1 · Carcinoid heart disease

Tumor mediators · endocardial plaques · right-sided valvular dysfunction

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning outcomes

Explain how vasoactive products from neuroendocrine tumors reach the endocardium.

Account for right-sided predominance and identify exceptions.

Recognize the gross and microscopic plaque pattern.

Link tricuspid insufficiency and pulmonary stenosis to altered flow.

Differentiate carcinoid plaques from other valve lesions.

Slide 3 · One disease across two organs

Functional neuroendocrine tumor

Circulating bioactive mediators

Endocardial and valve plaques

Hemodynamic valve disease

Tumor-derived products connect an extracardiac neoplasm to a distinctive cardiac morphology.

The cardiac pathology is not a primary tumor of the heart.

Slide 4 · Two related diagnoses—not synonyms

Carcinoid syndrome

Systemic manifestations of circulating tumor products

Flushing, diarrhea, dermatitis, bronchoconstriction

Carcinoid heart disease

Cardiac manifestation of exposure to tumor products

Glistening endocardial plaques and valve dysfunction

Slide 5 · The relevant tumor phenotype is secretory

Neoplasm

Well-differentiated neuroendocrine tumors can release bioactive products.

Functional behavior

Symptoms arise from secreted molecules, not from valve metastasis.

Cardiac outcome

A subset of patients with systemic syndrome develop plaques.

Slide 6 · Cardiac involvement is common, not universal

Cardiac manifestations in roughly one-half of patients who develop systemic carcinoid syndrome.

That estimate refers to patients with the systemic syndrome—not every patient with a neuroendocrine tumor.

Cardiac lesions usually appear in the setting of multiple hepatic metastases and sustained mediator access.

The estimate is approximate; It is not a patient-specific prediction.

Slide 7 · Digestive neuroendocrine tumor context

Most gastrointestinal neuroendocrine tumors are well differentiated.

The small intestine is an important site of origin.

Some tumors produce vasoactive substances that cause systemic carcinoid syndrome.

Cardiac injury follows mediator exposure rather than direct invasion of the valve.

Terminology

The book notes that “carcinoid” persists in use for many well-differentiated neuroendocrine tumors.

Slide 8 · The systemic syndrome is multisystem

Skin

Flushing and dermatitis; Gastrointestinal source text also describes sweating.

Gut

Diarrhea and colicky abdominal pain.

Airway

Bronchoconstriction or bronchospasm.

Slide 9 · Why many intestinal tumors do not cause the syndrome

Intestinal tumor secretion

Portal venous drainage

Hepatic metabolism

Less mediator reaching systemic blood

The liver normally inactivates circulating products from intestinal tumors.

This first-pass effect explains why secretory capacity alone need not produce the systemic syndrome.

Slide 10 · Liver metastases alter the exposure pathway

Multiple hepatic metastases

Products reach systemic blood

Right heart is exposed

Valvular plaques may develop

Cardiac lesions as generally arising after multiple liver metastases.

The qualifying phrase “typically” matters: An anatomic explanation, not an absolute rule.

Slide 11 · The first-pass model has two states

Predominantly portal clearance

Secretions enter portal flow.

Hepatic degradation limits systemic exposure.

Systemic escape

Extensive hepatic metastases or other bypass routes permit circulation of mediators.

The heart is subsequently exposed.

Slide 12 · Follow the blood: Gastrointestinal source to heart

Intestine / liver

Systemic veins

Right atrium → right ventricle

Pulmonary vessels

Left heart

Flow ordering is anatomical; The critical exposures occur in the right heart.

The pulmonary circulation provides a second biochemical barrier.

Slide 13 · Why the right heart is most often affected

First contact

The right-sided endocardium is exposed early to products in systemic venous blood.

Frequent targets

Right ventricular lining and tricuspid/pulmonary valve surfaces.

Functional pattern

Tricuspid insufficiency with pulmonary stenosis.

Slide 14 · Pulmonary inactivation protects the left side

Right ventricular outflow

Pulmonary vascular bed

Mediator degradation

Reduced left-heart exposure

The pulmonary vascular bed provides only partial protection.

Protection is conditional on source and intracardiac flow pathway.

Slide 15 · Anatomic exception: Right-to-left shunting

Right-heart mediator load

Atrial / septal communication

Right-to-left transit

Left-sided cardiac exposure

Right-to-left flow across a defect as a route to left-heart plaques.

The defect and direction of flow—not merely the presence of a defect—are crucial.

Slide 16 · Primary pulmonary carcinoids can affect the left heart

Primary lung carcinoid

Locally released products

Pulmonary venous / left-heart access

Left-sided plaque lesions

A pulmonary tumor does not require the same portal-hepatic escape pathway.

This exception is explicitly described in the cardiac section.

Slide 17 · Right versus left: Mechanisms, not rigid rules

Setting

Exposure logic

Expected cardiac emphasis

GI source with systemic mediators

Systemic venous blood reaches the right heart first

Mainly right heart

Right-to-left intracardiac flow

A portion of mediator-rich blood bypasses pulmonary degradation

Left heart possible

Primary pulmonary carcinoid

Tumor products can reach left cardiac circulation

Left heart possible

Slide 18 · The tumor releases several candidate mediators

Amines

Serotonin (5-hydroxytryptamine), histamine.

Peptides / enzymes

Kallikrein, bradykinin, tachykinins.

Lipid mediators

Prostaglandins.

Slide 19 · Serotonin: An important signal, not proven sole cause

Serotonin is also named 5-hydroxytryptamine (5-HT).

It among the mediators released by carcinoid tumors.

Higher plasma serotonin correlates with more severe cardiac lesions.

Correlation is not sufficient to establish that serotonin acts alone.

Evidence boundary

The textbook explicitly states that the causal identity among released mediators remains uncertain.

Slide 20 · The mediator mechanism remains partly unresolved

Observed

Bioactive products circulate in carcinoid syndrome.

Distinctive endocardial plaques occur.

Serotonin concentrations track severity.

Not established here

Which individual mediator is necessary.

Whether one mediator alone is sufficient.

A fully specified receptor-to-fibrosis pathway.

Slide 21 · Urinary 5-HIAA is a serotonin metabolite

Tumor serotonin secretion

Serotonin metabolism

Urinary 5-hydroxyindoleacetic acid

Association with lesion severity

5-HIAA means 5-hydroxyindoleacetic acid.

The text states a severity correlation; It does not supply a diagnostic cutoff or performance metric.

Slide 22 · A correlation is not a diagnostic criterion

Plasma serotonin

Tracks severity account.

Urinary 5-HIAA

A metabolite whose excretion correlates with severity.

Cardiac morphology

The distinguishing lesion remains a specific endocardial/valvular plaque pattern.

Slide 23 · Cardiac injury and systemic symptoms are different readouts

Systemic mediator effects

Flushing; Intestinal hypersecretion; Bronchoconstriction.

Clinical signs reflect diverse organ responses.

Cardiac tissue response

Plaque-like endocardial thickening.

Valve restriction or loss of competence.

Slide 24 · Fenfluramine provides a morphologic analogy

Carcinoid plaques with valve lesions associated with fenfluramine exposure.

Fenfluramine was an appetite suppressant that is no longer marketed.

The drug affects systemic serotonin metabolism.

An analogous lesion supports biologic plausibility but does not prove a unique causal pathway.

Slide 25 · Ergot alkaloids are another plaque analogy

Carcinoid-like valvular plaques have also been linked to ergot alkaloids.

The textbook refers to prior ergot use for migraine treatment.

These agents have relationships with serotonin handling.

Morphologic resemblance should not be mistaken for identical clinical exposure patterns.

Slide 26 · A left-sided drug-associated analogy

Methysergide / ergotamine

Reported with left-sided plaques after migraine treatment.

Passage through lung vessels is relevant to their metabolism.

GI carcinoid syndrome

Pulmonary mediator degradation usually limits left-sided lesions.

Right-sided plaque disease predominates.

Slide 27 · Shared morphology does not specify molecular causality

Observed valvular plaque similarity

Serotonin-related exposures

Plausible common biological contribution

Causal pathway still uncertain

Source comparisons are evidence of an association or analogy.

Avoid labeling a hypothetical receptor or molecular intermediate as established fact.

Slide 28 · Normal valve function depends on mobile leaflets

Atrioventricular valves

Tricuspid and mitral leaflets close to prevent backflow.

Semilunar valves

Pulmonary and aortic cusps open for ventricular outflow.

Tissue property

Mobility, pliability and structural integrity are required.

Slide 29 · Stenosis and insufficiency are different defects

Stenosis: Opening defect

Valve does not open completely.

Forward blood flow is obstructed.

Insufficiency: Closing defect

Valve does not close completely.

Blood regurgitates backward.

Slide 30 · Carcinoid plaques are endocardial lesions

Circulating mediators

Endocardial surface response

Plaque-like thickening

Valve or chamber lining involvement

The lesion is a surface-associated plaque rather than myocardial replacement.

Both valve leaflets and chamber endocardium may be involved.

Slide 31 · Gross morphology: Smooth glistening white plaques

Surface schematic: Pale plaque-like thickenings over intact deeper tissue

Conceptual depiction — not a gross specimen

Schematic depiction only—not a photograph of a specimen.

The adjective “plaque-like” describes an attached surface thickening.

Slide 32 · Right ventricular lining and tricuspid valve

Right ventricular endocardium

Tricuspid leaflet surface

Plaque-related deformation

Valve insufficiency may result

Figure 12.26A depicts the right ventricle and tricuspid valve.

The figure’s actual specimen is not reproduced because only its caption is available.

Slide 33 · Microscopy: The cellular and matrix components

Cells

Smooth muscle cells are present in the plaques.

Fibrillar component

Relatively sparse collagen fibers.

Dominant extracellular milieu

Matrix rich in acid mucopolysaccharides.

Slide 34 · A matrix-rich plaque is not simply dense collagen

Carcinoid plaque

Acid mucopolysaccharide-rich ground substance.

Smooth muscle cells with sparse collagen fibers.

Incorrect oversimplification

“Only dense collagen scar.”

“A destructive inflammatory vegetation.”

Slide 35 · Histologic location: Surface over preserved tissue

Plaque: Cells + acid mucopolysaccharide-rich matrix

Underlying endocardial / valvular tissue

Myocardium: Unaffected in illustrated lesion

Schematic cross-section — native editable drawing, not photomicrograph

The source stresses that underlying structures remain intact.

This is a conceptual cross-section; Not original histology.

Slide 36 · Movat stain: Which elements are described?

Plaque matrix

Blue-green acid mucopolysaccharide-rich lesion in Fig. 12.26B.

Underlying region

Myocardial elastic tissue appears black in the caption.

Interpretation

Underlying myocardium is unaffected in the illustrated specimen.

Slide 37 · Do not equate thickening with tissue destruction

Documented in carcinoid disease

Surface-associated plaque thickening.

Underlying structures intact.

Different mechanism in IE

Large friable vegetations may accompany injury.

An invasive infection can cause leaflet destruction.

Slide 38 · Tricuspid valve: Functional failure

Endocardial plaque on tricuspid valve

Distorted leaflet function

Incomplete closure

Tricuspid insufficiency

Robbins specifically lists tricuspid insufficiency as typical.

Incomplete closure describes the physiological definition of regurgitation.

Slide 39 · Tricuspid insufficiency produces backflow

Right ventricle contracts

Incompetent tricuspid valve

Backward flow toward right atrium

Right-sided volume load

Direction of backflow follows valve anatomy and the generic definition of insufficiency.

Parent cardiac-pathophysiology text links volume overload with chamber dilation.

Slide 40 · Pulmonary valve: Obstructed outflow

Carcinoid plaque on pulmonary valve

Reduced cuspal opening

Obstruction of forward flow

Pulmonary stenosis

Robbins specifically lists pulmonary stenosis as typical.

Incomplete opening is the parent chapter definition of stenosis.

Slide 41 · Pulmonary stenosis increases outflow resistance

Right ventricular ejection

Narrowed pulmonary valve orifice

Resistance to forward flow

Right ventricular pressure load

The pressure-load consequence is a physiological interpretation of stenosis.

Pressure overload is related to hypertrophy in the parent cardiac section.

Slide 42 · Two valves, two flow problems

Valve

Typical disturbance

Direct flow consequence

Tricuspid

Insufficiency

Backflow into right atrium

Pulmonary

Stenosis

Obstruction of forward flow into pulmonary artery

Both involved

Mixed right-sided valve burden

Potential combined volume and pressure loading

Slide 43 · Right-heart load can be mixed

Volume component

Tricuspid regurgitation allows return flow toward the right atrium.

Pressure component

Pulmonary stenosis creates resistance to right ventricular outflow.

Possible adaptation

General ventricular responses include hypertrophy and/or dilation.

Slide 44 · Right-heart failure is a possible downstream consequence

Chronic right-sided valve dysfunction

Sustained hemodynamic load

Limited compensatory capacity

Potential right-sided heart failure

Heart failure in terms of inadequate pumping or elevated filling pressures.

The valve-to-heart-failure pathway is clinicopathologic inference; The carcinoid subsection does not quantify it.

Slide 45 · Right-sided versus left-sided congestion

Right-heart failure pattern

Engorgement of systemic and portal venous circulations.

Pulmonary congestion is comparatively limited in isolated right-sided failure.

Left-heart failure pattern

Pulmonary venous congestion and edema predominate.

A different hemodynamic site of backlog.

Slide 46 · A lesion’s layer and function answer different questions

Question

Morphologic answer

Physiologic answer

Where is it?

Valve leaflets and chamber endocardium

Right-sided valves predominate

What is it made of?

Cells, sparse collagen, mucopolysaccharide-rich matrix

—

What does it do?

Thickening / deformation

Tricuspid insufficiency; pulmonary stenosis

Slide 47 · Gross plaque and sterile thrombus are not equivalent

Carcinoid plaque

Glistening white endocardial thickening.

Matrix and smooth muscle cells; Deeper tissue intact.

Nonbacterial thrombotic endocarditis

Small sterile bland thrombi attached to valve leaflets.

Loose adherence; Potential embolic source.

Slide 48 · Nonbacterial thrombotic endocarditis: Different substrate

Nature

Sterile thrombotic vegetation, not a mucopolysaccharide-rich plaque.

Context

May accompany malignancy or hypercoagulable states.

Consequence

Loose thrombi can embolize even if valve function is little affected.

Slide 49 · Libman–Sacks disease adds inflammation

Carcinoid heart disease

Surface plaque with preserved underlying structures.

Bioactive tumor products implicated.

Libman–Sacks endocarditis

Sterile vegetations in lupus.

Immune-complex injury, valvulitis, fibrinoid necrosis.

Slide 50 · Infective endocarditis is another distinct process

Carcinoid plaque

Glistening white, plaque-like thickening.

No primary valve infection is invoked in pathogenesis.

Infective endocarditis

Microbe-associated friable vegetations.

Destructive leaflet infection may occur.

Slide 51 · Four lesions: Choose by tissue response

Entity

Dominant lesion

Context / distinguishing clue

Carcinoid

Endocardial matrix-rich plaque

Functional NET / carcinoid syndrome

NBTE

Bland thrombotic vegetation

Hypercoagulability; malignancy

Libman–Sacks

Immune valvulitis / sterile vegetation

Systemic lupus erythematosus

Infective endocarditis

Infected, often destructive vegetation

Microbial infection

Slide 52 · What a pathologist can infer from the plaque

A smooth white valve or endocardial plaque suggests a surface-deposition / tissue-response process.

A mucopolysaccharide-rich matrix with smooth muscle cells supports the reported carcinoid pattern.

Preservation of deeper structures distinguishes this lesion from destructive processes.

Clinical correlation is needed to connect that morphology to a functional neuroendocrine tumor.

Important limit

A schema or descriptive morphology does not replace a real specimen or full clinical work-up.

Slide 53 · Diagnostic synthesis starts with the full phenotype

Functioning NET / systemic syndrome

Biochemical mediator exposure

Predominantly right-sided valve disease

Characteristic endocardial plaques

Each stage adds explanatory support; No single step is an absolute diagnostic requirement in the provided text.

Specific imaging protocols or formal clinical criteria are not provided by the source.

Slide 54 · What do serotonin and 5-HIAA tell us?

Supported by Robbins

Plasma serotonin correlates with cardiac lesion severity.

Urinary 5-HIAA excretion also correlates with lesion severity.

Not provided by Robbins passage

Sensitivity or specificity for identifying plaques.

A cutoff that defines cardiac involvement.

Proof of a sole causal mediator.

Slide 55 · Avoid five frequent reasoning errors

Do not assume every neuroendocrine tumor produces the systemic syndrome.

Do not assume carcinoid heart disease always affects the left heart or never can.

Do not substitute “dense collagen scar” for the described matrix-rich plaque.

Do not interpret serotonin association as mechanistic proof.

Do not equate carcinoid plaques with cancer-associated NBTE.

Slide 56 · Application I: Intestinal tumor with hepatic spread

Hypothetical teaching vignette

A patient has an intestinal neuroendocrine tumor with multiple hepatic metastases, episodic flushing and diarrhea.

Subsequent evaluation detects right-sided valve dysfunction.

Question: Explain the exposure pathway and name the two typical valve defects.

Discuss the inference; The next slide develops the reasoning.

Slide 57 · Application I: Connect each observation to a mechanism

Finding

Source-based mechanistic inference

Intestinal secretory tumor

Potential vasoactive mediator source

Multiple liver metastases

Hepatic inactivation barrier may be bypassed

Flushing and diarrhea

Systemic carcinoid syndrome

Right-sided valve lesions

Typical carcinoid cardiac distribution

Slide 58 · Application II: Left-sided lesions

Hypothetical teaching vignette

A patient with secretory carcinoid manifestations has a left-sided valve plaque.

A clinician considers a right-to-left intracardiac shunt or a primary pulmonary carcinoid.

Question: Why are these biologically plausible exceptions to the usual sidedness?

Discuss the inference; The next slide develops the reasoning.

Slide 59 · Application II: Identify the missing barrier

Right-to-left shunt

Mediator-rich systemic venous blood can pass toward the left side without full pulmonary degradation.

Primary pulmonary source

Secretion occurs within the pulmonary compartment rather than upstream of hepatic first-pass clearance.

Slide 60 · Application III: Plaque versus vegetation

Hypothetical teaching vignette

An excised valve shows smooth, glistening white endocardial thickening.

Microscopic description includes acid mucopolysaccharide-rich matrix, smooth muscle cells and preserved deeper structures.

Question: Which lesion pattern is favored, and which common alternatives are morphologically different?

Discuss the inference; The next slide develops the reasoning.

Slide 61 · Application III: Decisive tissue features

Feature

Supports carcinoid-type lesion

Argues for another process

Surface appearance

Smooth glistening plaque

Friable vegetation

Composition

Mucopolysaccharide-rich matrix

Bland thrombus or inflammatory necrosis

Deeper structure

Preserved

Destruction in aggressive infection

Slide 62 · Reconstruct the full pathophysiology

Secretory NET with systemic access

Mediator exposure in right heart

Matrix-rich endocardial plaques

Tricuspid regurgitation / pulmonary stenosis

The causal identity of individual mediators remains uncertain.

Left-sided lesions can occur with altered intracardiac flow or pulmonary origin.

Slide 63 · Five defensible conclusions

Carcinoid heart disease is an endocardial and valvular manifestation of circulating tumor products.

Hepatic and pulmonary metabolism explain its common clinical and anatomic pattern.

Plaques are glistening white, matrix-rich, and leave the underlying tissue intact.

Tricuspid insufficiency and pulmonary stenosis are characteristic right-sided effects.

Biomarker association is not proof that serotonin alone causes the lesions.

Slide 64 · Primary reading and interpretive boundaries

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th edition (2026). Chapter 12, “The Heart”: carcinoid heart disease and valvular pathology.

Chapter 17, “The Gastrointestinal Tract”: well-differentiated neuroendocrine tumors and carcinoid syndrome.

Chapter 15, “The Lung”: pulmonary carcinoid tumors and functional secretory manifestations.

Illustrations in this lecture are original editable schematics—not textbook figures or observed specimens.